Abstracts of recent articles about mesothelioma in medical journals. Many of these are available through PubMed, a search engine of the National Library of Medicine. Overview of mesothelioma in PDF format. See our page on how to read medical abstracts.
- Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
- Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
- Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype.
- Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium.
- Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma.
- Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
- Malignant Pleural Mesothelioma After Household Exposure to Asbestos.
- Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.
- Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.
- Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
- The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
- Lung Cancer Mutation Consortium news
- Onconase mediated NFKβ downregulation in malignant pleural mesothelioma
- Antiproliferative effect of Aurora kinase targeting in mesothelioma.
- Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma.
- Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
- Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
- Induction of tubulin polymerization and apoptosis in malignant mesothelioma cells by a new compound JBIR-23.
- Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.
- Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma
- Malignant mesothelioma following treatment for Hodgkin’s disease
- Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
- Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis.
- A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
- A theoretical quantitative model for evolution of cancer chemotherapy resistance
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
- Malignant Pleural Mesothelioma After Household Exposure to Asbestos
- Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
- Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.
- A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
- Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.
- Positron emission tomography predicts survival in malignant pleural mesothelioma.
- Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
- Three Emerging New Drugs for NSCLC: Pemetrexed, Bortezomib, and Cetuximab
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
- Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies.
- Problems in mesothelioma diagnosis.
- Therapeutic strategies for resectable malignant pleural mesothelioma
- Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.
- Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.
- Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases
- Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
- Second-line treatment for malignant pleural mesothelioma
- Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
- Genome-Wide PComparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.rofile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype
- Fatal hemopericardial tamponade due to primary pericardial mesothelioma: a case report
- Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
- Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
- Diagnosis and staging of pleural mesothelioma – English language abstract of a Japanese paper.
- Malignant mesothelioma – Review from the Orphanet Journal of Rare Diseases
- Malignant pleural mesothelioma: an update on biomarkers and treatment.
- Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
- Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
- Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma
- Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma
- Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients
- Malignant pleural mesothelioma: computed tomography and correlation with histology.
- “Mucin-positive” epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall.
- Long-term mortality from pleural and peritoneal cancer after exposure to asbestos: Possible role of asbestos clearance.
- Malignant mesothelioma following treatment for Hodgkin’s disease
- Susceptibility and resistance in the genesis of asbestos-related mesothelioma
- Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study
- Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.
- Asbestos-related cancer risk in the presence of asbestosis or pleural plaques
- Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.
- Multidisciplinary treatment of malignant pleural mesothelioma.
- An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers.
- Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma.
- Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence.
- Long-term mortality from pleural and peritoneal cancer after exposure to asbestos: Possible role of asbestos clearance.
